Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record.

A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study

Open access
Ren, Zhigang, Luo, Hong, Yu, Zujiang, Song, Jingchao, Liang, Lan, Wang, Ling, Wang, Haiyu, Cui, Guangying, Liu, Yong, Wang, Jin, Li, Qingquan, Zeng, Zhaohai, Yang, Shengkun, Pei, Guangzhong, Zhu, Yonghui, Song, Wenbin, Yu, Wenquan, Song, Chuanjun, Dong, Lihong, Hu, Chuansong, Du, Jinfa, Chang, Junbiao · 2020 · Advanced Science

Abstract

Coronavirus disease 2019 (COVID‐19) has spread worldwide. To date, no specific drug for COVID‐19 has been developed. Thus, this randomized, open‐label, controlled clinical trial (ChiCTR2000029853) was performed in China. A total of 20 mild and common COVID‐19 patients were enrolled and randomly assigned to receive azvudine and symptomatic treatment (FNC group), or standard antiviral and symptomatic treatment (control group). The mean times of the first nucleic acid negative conversion (NANC) of ten patients in the FNC group and ten patients in the control group are 2.60 (SD 0.97; range 1–4) d and 5.60 (SD 3.06; range 2–13) d, respectively (p = 0.008). The mean times of the first NANC of four newly diagnosed subjects in the FNC group and ten subjects in the control group are 2.50 (SD 1.00; range 2–4) d and 9.80 (SD 4.73; range 3–19) d, respectively (starting from the initial treatment) (p = 0.01). No adverse events occur in the FNC group, while three adverse events occur in the control group (p = 0.06). The preliminary results show that FNC treatment in the mild and common COVID‐19 may shorten the NANC time versus standard antiviral treatment. Therefore, clinical trials of FNC treating COVID‐19 with larger sample size are warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/advs.202001435

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 171

Metadata

Authors
Ren, Z., Luo, H., Yu, Z., Song, J., Liang, L., Wang, L., Wang, H., Cui, G., Liu, Y., Wang, J., Li, Q., Zeng, Z., Yang, S., Pei, G., Zhu, Y., Song, W., Yu, W., Song, C., Dong, L., Hu, C., Du, J., & Chang, J.
Venue
Advanced Science
Publisher
Wiley
Published
2020-08-13
Volume
7
Issue
19
Pages
e2001435-e2001435
ISSN
2198-3844 (ISSN-L)
OpenAlex
W3043552482
Cited by
171
References
0
FWCI
2.63
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study. https://app.cochat.ai/papers/10.1002/advs.202001435
The paper
Ren, Z., Luo, H., Yu, Z., Song, J., Liang, L., Wang, L., Wang, H., Cui, G., Liu, Y., Wang, J., Li, Q., Zeng, Z., Yang, S., Pei, G., Zhu, Y., Song, W., Yu, W., Song, C., Dong, L., . . . Chang, J. (2020). A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study. Advanced Science. https://doi.org/10.1002/advs.202001435

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.